Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Current Blog Category: Disease
3 Gene Therapy Companies Powering a Revolution in Rare Disease Cures
Contributing Author: Gina Hagler Gene therapy companies are powering a revolution in rare disease cures by offering treatments that target the genetic cause of the disease. Rather than try different combinations of chemicals to create a small-molecule treatment as is the case with traditional pharmaceuticals,…
Read More
5 Reasons Gene Therapy Companies are Vital to the Future of Biopharma
Contributing Author: Gina Hagler Pharmaceutical companies have been developing therapies to treat or prevent disease since the end of the 19th century. Chemical compounds are used to create these drugs and medications. The resulting small-molecule drugs – think aspirin – are ingested, metabolized and circulate…
Read More
5 Biotech Companies in Maryland That May Make History in 2021
Contributing Author: Gina Hagler These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in trials for a variety of genetic diseases. REGENXBIO is a publicly-traded company that develops products for one-and-done, single-dose solutions addressing genetic defects. Their…
Read More
What Star Wars Can Teach Us About Cell Therapy Investments
Contributing Author: Gina Hagler It’s difficult to believe there is anything that Star Wars can teach us about cell therapy, let alone cell therapy investment. However, in 2016 Tom Isaacs, then President and Co-founder of the Cure Parkinson’s Trust, drew parallels between the Star Wars…
Read More
The Berlin Patient’s Success Produces A Flurry of Activity
The Berlin Patient’s success provided optimism that there was a way to permanently disable HIV and eradicate it from an infected person. While a bone marrow transplant is not appropriate for most HIV patients, what we have learned from his experience has provided us clues…
Read More
7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News
Contributing Author: Gina Hagler Maryland has one of the largest life science clusters in the United States with more than 500 biotech companies. In addition to several state-of-the-art labs, Maryland is home to the NIH in Bethesda. Research opportunities, as well as BS and MS degree…
Read More
The Race for a COVID Vaccine Foreshadows a Medical Revolution
Contributing Author Luke Williams, Sales and Marketing Conventional vaccine development can take many years, yet vaccines targeting the novel coronavirus were approved and began distribution in under 12 months. Pfizer, Moderna, and AstraZeneca have led the race, announcing promising interim results in their vaccine trials,…
Read More
Rare Diseases: Why Are They Difficult to Cure?
Contributing Author: Gina Hagler Approximately 7,000 rare diseases affect 350-500 million people worldwide. The majority of these (80%) are monogenic, so-called because these genetic disorders are caused by a mutation in a single gene. While gene therapy holds great promise for the treatment of monogenic diseases…
Read More
The History of HIV Cure Research: Reaching for a Cure
Contributing Author: Gina Hagler A new immune deficiency illness came on the scene in 1981. In the years immediately following, four questions arose that indicated the uncertainty of the time: What was this illness? How was it transmitted? Could it be treated? Could it be cured?…
Read More
The History of HIV Cure Research: The Latest Research in BioPharma
Contributing Author: Gina Hagler In the forty years since the HIV/AIDS pandemic began in 1981, researchers have learned a lot about this disease that destroys the immune system. Early on, they identified the method of transmission and the means of HIV replication. They went on to…
Read MoreSubscribe to Receive our Blog Updates
Subscribe to our blog updates to be notified when we release new content!
